• Showing all 6 results

  • Atezolizumab

    Description:
    Analog to the therapeutic anti-PDL1 antibody Atezolizumab, also named Tecentriq.
    Cat. No.
    AB-ATEZO
  • View product
  • Blinatumomab

    Description:
    Analog to the therapeutic Blinatumomab, also known as Blincyto. Blinatumomab is a  BiTE directed to CD3 and CD19.
    Cat. No.
    AB-BLINA
  • View product
  • Canakinumab

    Description:
    Analog to Canakinumab, a therapeutic antibody against IL1β.
    Cat. No.
    AB-CAN
  • View product
  • Ivonescimab

    Description:
    Analog to the therapeutic Ivonescimab, an bispecific antibody directed to PD-1 and VEGF.
    Cat. No.
    AB-IVON
  • View product
  • Pembrolizumab

    Description:
    Analog to the therapeutic antibody Pembrolizumab, directed to PD-1 protein.  
    Cat. No.
    AB-PEMBRO
  • View product
  • Trastuzumab

    Description:
    Analog to  the therapeutic Trastuzumab antibody. Anti-HER2 antibody also known as Herceptin.
    Cat. No.
    AB-TRAST
  • View product

Custom services

Contact us for a free consultation or if you need a quote